Lake Street Advisors Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Lake Street Advisors Group’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-83,857	Closed	-$3.43M	–	665
2024 Q2	$3.43M	Hold	83,857	–	–	0.16%	84
2024 Q1	$3.54M	Hold	83,857	–	–	0.17%	88
2023 Q4	$3.56M	Hold	83,857	–	–	0.18%	85
2023 Q3	$1.83M	Buy	+83,857	New	+$2.1M	0.11%	124

Other funds holding CERE

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Lake Street Advisors Group's CERE Position: Q3 2024 in Review

Lake Street Advisors Group sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 83,857 shares — an estimated $3.43M sold.

Lake Street Advisors Group first reported a position in CERE in Q3 2023 and held it in 4 quarters. The position peaked at $3.56M in Q4 2023. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

Lake Street Advisors Group reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Lake Street Advisors Group sold 83,857 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $3.43M.
Lake Street Advisors Group first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2023 and held it in 4 quarters.
Lake Street Advisors Group's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $3.56M in Q4 2023.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Lake Street Advisors Group's 13F filing for Q3 2024, filed 23 Oct 2024.